Pacific Biometrics: Rapid response for biomarker-heavy adaptive trials
In a recent report to the Board, the CEO of Pacific Biometrics (PBI), Ron Helm, reported a second trend driving growth is the fast turnaround work the company performs developing assays for a growing scope of biomarkers, which favors “smaller labs, like PBI, that are nimble and flexible, and plays into our biomarker development strength.” Read more »